was resistance to the second and third generation cephalosporins (cefuroxim: 80%, ceftriaxon: 57.1% and ceftazidim: 63.6%)), quinolons (resistance to levofloxacin, ciprofloxacin and ofloxacin were 38.5%, 50% and 50%, respectively), resistance to aminosid (amikacin: 25% and gentamycin: 37.5%) and oxacillin (100%), reduced sensitivity to carbapenem (imipenem: 92.9% and meropenem: 62.5%), sensitive to vancomycin (83.3%).